Enhanced protection by melatonin and meloxicam combination in a middle cerebral artery occlusion model of acute ischemic stroke in rat

Canadian Journal of Physiology and Pharmacology

Volumn 80, Issue 3, 2002, Pages 210-217

  Gupta, Y K ^a   Chaudhary, Geeta ^a   Sinha, Kusum ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Antioxidant; Focal ischemia; Melatonin; Meloxicam

Indexed keywords

ANTIOXIDANT; CHLORAL HYDRATE; CYCLOOXYGENASE 2 INHIBITOR; MALONALDEHYDE; MELATONIN; MELOXICAM; TRIPHENYLTETRAZOLIUM;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; LOCOMOTION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR PERFORMANCE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

ANIMALS; ANTIOXIDANTS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DRUG THERAPY, COMBINATION; INFARCTION, MIDDLE CEREBRAL ARTERY; ISOENZYMES; MALE; MALONDIALDEHYDE; MELATONIN; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, WISTAR; THIAZINES; THIAZOLES;

EID: 0036203016     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y02-052     Document Type: Article

References (29)

1. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats
2. Role of oxidants in ischemic brain damage
3. Cyclooxygenase-2 messenger RNA induction in focal cerebral ischemia
4. Protective effects of melatonin in ischemic brain injury
5. Clinical pharmacokinetics of meloxicam. A cycloxygenase-2 preferential non-steroidal anti-inflammatory drug
6. Inflammatory mediators and brain injury: The role of cytokines and chemokines in stroke and CNS diseases
7. Pinealectomy aggravates and melatonin administration attenuates brain damage in focal ischemia
8. Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia
9. Experimental studies of ischemic brain edema: A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area
10. Intracerebroventricular administration of streptozotocin causes long-term diminution in learning and memory abilities and intracerebral energy metabolism in adult's rats
11. Neuroprotective effect of melatonin on brain damage induced by acute global cerebral ischemia in cats
12. Melatonin decreases production of hydroxyl radical during cerebral ischemia-reperfusion
13. Production of reactive oxygen species after reperfusion in vitro and in vivo
14. Age related learning deficits in transgenic mice expressing the 721-amino acid isoform of human beta-amyloid precursor protein
15. Cyclo-oxygenase 2 gene expression in neurons contributes to ischemic brain damage
16. Assay of lipid peroxides in animals tissue by thiobarbituraic acid reaction
17. Limiting neurological damage after stroke
18. Melatonin: Lowering the high price of free radicals
19. Pharmacological actions of melatonin in oxygen radical pathophysiology
20. Reactive oxygen intermediates, molecular damage and aging; relation to melatonin
21. Correlation between motor impairment and infarct volume after permanent and transient middle artery occlusion in the rat
22. Nitric oxide activates cycoloxygenase enzymes
23. Neuroprotective efficacy of combination therapy with two different antioxidants in rats subjected to transient focal ischemia
24. Mediation of inflammation by cyclooxygenase-2
25. Glutamate, calcium and free radicals as mediators of ischemic brain damage
26. Effect of melatonin on ischemia reperfusion injury induced by middle cerebral artery occlusion in rats
27. Biochemistry of prostaglan-din endoperoxide H synthase-1 and synthase-2 and their differential susceptibility to non steroidal anti-inflammatory drugs
28. Melatonin protects against ischemia and reperfusion-induced oxidative lipid and DNA damage in fetal rat brain
29. Enhanced neuroprotection and reduced hemorrhagic incidence in focal cerebral ischemia of rat by low dose combination therapy of urokinase and topiramate